Skip to main content
SpringerLink
Log in

Neuroinflammation and Sjogren’s Syndrome

  • Chapter
  • First Online:
Neuroimmune Diseases

Part of the book series: Contemporary Clinical Neuroscience ((CCNE))

  • 1126 Accesses

Abstract

Sjogren’s syndrome (SS) is a chronic organ-specific autoimmune disease mainly involving exocrine glands such as lacrimal and salivary glands. SS may also involve central and peripheral nervous system with variable prevalence due to differences in diagnostic criteria and in time length to reach diagnosis. Clinical features of the central nervous involvement share similarities with multiple sclerosis (MS) and neuromyelitis optica spectrum disorders (NMOSD), two major neuroimmune disorders. SS may even coexist with MS or NMOSD. Sensory neuropathy, chronic polyradiculoneuropathy, cranial neuropathies as well as small fibre neuropathy are the main manifestations of the peripheral nervous system involvement. The pathogenic mechanism underlying neuro-SS is unclear even though molecular mimicry and epitope spreading have been hypothesized for central nervous involvement, whereas vasculitis with or without direct damage to nerve could account for peripheral nervous involvement. Treatment is mainly based on immunosuppressive therapies requiring a close cooperation between neurologists and rheumatologists to achieve the best management.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 229.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 299.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 299.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Peri Y, Agmon-Levin N, Theodor E, Shoenfeld Y. Sjögren’s syndrome, the old and the new. Best Pract Res Clin Rheumatol. 2012;26:105–17.

    Article  CAS  Google Scholar 

  2. Vanderlugt CL, Miller SD. Epitope spreading in immune-mediated diseases: implications for immunotherapy. Nat Rev Immunol. 2002;2:85–95.

    Article  CAS  Google Scholar 

  3. Noseworthy JH, Bass BH, Vandervoort MK, et al. The prevalence of primary Sjögren’s syndrome in a multiple sclerosis population. Ann Neurol. 1989;25:95–8.

    Article  CAS  Google Scholar 

  4. Annunziata P, De Santi L, Di Rezze S, et al. Clinical features of Sjogren’s syndrome in patients with multiple sclerosis. Acta Neurol Scand. 2011;124:109–14.

    Article  CAS  Google Scholar 

  5. Mirò J, Peña-Sagredo JL, Berciano J, Insùa S, Leno C, Velarde R. Prevalence of primary Sjögren’s syndrome in patients with multiple sclerosis. Ann Neurol. 1990;27:582–4.

    Article  Google Scholar 

  6. Sandberg-Wollheim M, Axell T, Hansen B, et al. Primary Sjögren’s syndrome in patients with multiple sclerosis. Neurology. 1992;42:845–7.

    Article  CAS  Google Scholar 

  7. de Seze J, Devos D, Castelnovo G, et al. The prevalence of Sjögren syndrome in patients with primary progressive multiple sclerosis. Neurology. 2001;57:1359–63.

    Article  Google Scholar 

  8. Sène D, Jallouli M, Lefaucheur JP, et al. Peripheral neuropathies associated with primary Sjögren syndrome: immunologic profiles of nonataxic sensory neuropathy and sensorimotor neuropathy. Medicine (Baltimore). 2011;90:133–8.

    Article  Google Scholar 

  9. Delalande S, de Seze J, Fauchais AL, et al. Neurologic manifestations in primary Sjögren syndrome: a study of 82 patients. Medicine (Baltimore). 2004;83:280–91.

    Article  Google Scholar 

  10. Gono T, Kawaguchi Y, Katsumata Y, et al. Clinical manifestations of neurological involvement in primary Sjögren’s syndrome. Clin Rheumatol. 2011;30:485–90.

    Article  Google Scholar 

  11. Manthorpe R, Asmussen K, Oxholm P. Primary Sjogren’s syndrome: diagnostic criteria, clinical features, and disease activity. J Rheumatol. 1997;24(suppl):8–11.

    Google Scholar 

  12. Kassan SS, Moutsopoulos HM. Clinical manifestations and early diagnosis of Sjogren syndrome. Arch Intern Med. 2004;164:1275–84.

    Article  Google Scholar 

  13. Papiris SA, Maniati M, Constantopoulos SH, et al. Lung involvement in primary Sjogren’s syndrome is mainly related to the small airway disease. Ann Rheum Dis. 1999;58:61–4.

    Article  CAS  Google Scholar 

  14. Bailey RR, Swainson CP. Renal involvement in Sjogren’s syndrome. N Z Med J. 1986;99:579–80.

    CAS  PubMed  Google Scholar 

  15. Skopouli FN, Dafni U, Ioannidis JP, Moutsopoulos HM. Clinical evolution, and morbidity and mortality of primary Sjogren’s syndrome. Semin Arthritis Rheum. 2000;29:296–304.

    Article  CAS  Google Scholar 

  16. Kassan SS. Managing dry eyes and dry mouth in Sjogren’s syndrome. Am J Manag Care. 2001;7(suppl):S444–50.

    CAS  PubMed  Google Scholar 

  17. Ostuni P, Botsios C, Sfriso P, et al. Prevalence and clinical features of fibromyalgia in systemic lupus erythematosus, systemic sclerosis, and Sjogren’s syndrome. Minerva Med. 2002;93:203–9.

    CAS  PubMed  Google Scholar 

  18. Tsokos M, Lazarou SA, Moutsopoulos HM. Vasculitis in primary Sjogren’s syndrome: histologic classification and clinical presentation. Am J Clin Pathol. 1987;88:26–31.

    Article  CAS  Google Scholar 

  19. Lafitte C. Neurologic manifestations of primary Gougerot-Sjögren syndrome. Rev Neurol. 1998;154:658–73.

    CAS  PubMed  Google Scholar 

  20. Massara A, Bonazza S, Castellino G, et al. Central nervous system involvement in Sjögren’s syndrome: unusual, but not unremarkable-clinical, serological characteristics and outcomes in a large cohort of Italian patients. Rheumatology (Oxford). 2010;49:1540–9.

    Article  Google Scholar 

  21. Alexander EL, Arnett FC, Provost TT, Stevens MB. Sjögren’s syndrome: association of anti-Ro(SS-A) antibodies with vasculitis, hematologic abnormalities, and serologic hyperreactivity. Ann Intern Med. 1983;98:155–9.

    Article  CAS  Google Scholar 

  22. Alexander GE, Provost TT, Stevens MB, Alexander EL. Sjögren syndrome: central nervous system manifestations. Neurology. 1981;31:1391–6.

    Article  CAS  Google Scholar 

  23. Flachenecker P. Autonomic dysfunction in Guillain-Barré syndrome and multiple sclerosis. J Neurol. 2007;254:96–101.

    Article  Google Scholar 

  24. Tsai KY, Tsai CP, Liao N. Sjögren’s syndrome with central nervous system involvement presenting as multiple sclerosis with failure response to beta-interferon. Eur Neurol. 2001;45:59–60.

    Article  CAS  Google Scholar 

  25. De Santi L, Costantini MC, Annunziata P. Long time interval between multiple sclerosis onset and occurrence of primary Sjögren’s syndrome in a woman treated with interferon-beta. Acta Neurol Scand. 2005;112:194–6.

    Article  Google Scholar 

  26. Wingerchuk DM, Banwell B, Bennett JL, et al. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology. 2015;85:177–89.

    Article  Google Scholar 

  27. Pavlakis PP, Alexopoulos H, Kosmidis ML, et al. Peripheral neuropathies in Sjogren syndrome: a new reappraisal. J Neurol Neurosurg Psychiatry. 2011;82:798–802.

    Article  Google Scholar 

  28. Yamamoto K. Pathogenesis of Sjögren’s syndrome. Autoimmun Rev. 2003;2:13–8.

    Article  Google Scholar 

  29. Gemignani F, Marbini A, Pavesi G, et al. Peripheral neuropathy associated with primary Sjogren’s syndrome. J Neurol Neurosurg Psychiatry. 1994;57:983–6.

    Article  CAS  Google Scholar 

  30. Vitali C, Bombardieri S, Jonsson R, et al. Classification criteria for Sjögren’s syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis. 2002;61:554–8.

    Article  CAS  Google Scholar 

  31. Coates T, Slavotinek JP, Rischmueller M, et al. Cerebral white matter lesions in primary Sjogren’s syndrome: a controlled study. J Rheumatol. 1999;26:1301–5.

    CAS  PubMed  Google Scholar 

  32. De Andrés C, Guillem A, Rodriguez-Mahou M, et al. Frequency and significance of anti-Ro (SSA) antibodies in multiple sclerosis patients. Acta Neurol Scand. 2001;104:83–7.

    Article  Google Scholar 

  33. Masi G, Annunziata P. Sjogren’s syndrome and multiple sclerosis: two sides of the same coin? Autoimmun Rev. 2016;15:457–61.

    Article  Google Scholar 

  34. Milo R, Miller A. Revised diagnostic criteria of multiple sclerosis. Autoimmun Rev. 2014;13:518–24.

    Article  Google Scholar 

  35. Drori T, Chapman J. Diagnosis and classification of neuromyelitis optica (Devic’s syndrome). Autoimmun Rev. 2014;13:531–3.

    Article  CAS  Google Scholar 

  36. Psianou K, Panagoulias I, Papanastasiou AD, et al. Clinical and immunological parameters of Sjogren’s syndrome. Autoimmun Rev. 2018;17:1053–64.

    Article  CAS  Google Scholar 

  37. Bruscolini A, Sacchetti M, La Cava M, et al. Diagnosis and management of neuromyelitis optica disorders – an update. Autoimmun Rev. 2018;17:195–200.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine, Surgery and Neurosciences, Clinical Neuroimmunology Unit, University of Siena, Siena, Italy

    Pasquale Annunziata

Authors
  1. Pasquale Annunziata
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Pasquale Annunziata .

Editor information

Editors and Affiliations

  1. Medical Education Promotion Center, Tokyo Medical University, Tokyo, Japan

    Hiroshi Mitoma

  2. Department of Neurology, CHU-Charleroi, Charleroi, Belgium, Department of Neurosciences, University of Mons, Mons, Belgium

    Mario Manto

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Annunziata, P. (2019). Neuroinflammation and Sjogren’s Syndrome. In: Mitoma, H., Manto, M. (eds) Neuroimmune Diseases. Contemporary Clinical Neuroscience. Springer, Cham. https://doi.org/10.1007/978-3-030-19515-1_23

Download citation

Publish with us

Policies and ethics

Search

Navigation